Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Jubilant's Radiopharma Business to expand positron emission tomography radiopharmacy network
PICCOLO trial met its primary endpoint of objective response rate (ORR)
Additional data from APPRAISE ATP trial reinforce modular therapy approach
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Subscribe To Our Newsletter & Stay Updated
